S.S. Wagers
- Associated factors with persistent airflow limitation in asthma in U-BIOPREDBy A. Wagener, D. Gibeon, X. Yang, A. Sousa, J. Corfield, D. Shaw, S. Fowler, L. Fleming, J. Riley, L. Jeyasingham, A. Rowe, K. Fichtner, G. Roberts, P. Bakke, F. Singer, T. Geiser, U. Frey, I. Horvarth, R. Polosa, K. Bønnelykke, N. Krug, R. Middelveld, S.-E. Dahlen, B. Dahlen, G. Hedlin, S. Hashimoto, B. Nordlund, J. Musial, A. Woodcock, C. Murray, L. Pahus, P. Chanez, D. Myles, C. Compton, T.W. Higenbottam, P. Montuschi, J. Vestbo, L. Larsson, T. Sandstrom, H. Bisgaard, S.S. Wagers, P.H. Howarth, E.H. Bel, R. Djukanovic, F. Chung and P. SterkA. Wagener2Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsD. Gibeon1NHLI, Imperial College London, London, United KingdomX. Yang1NHLI, Imperial College London, London, United KingdomA. Sousa3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomJ. Corfield4Clinical Research, AstraZeneca, Lund, SwedenD. Shaw5Nottingham Respiratory Research Unit, Nottingham City Hospital, Nottingham, United KingdomS. Fowler6Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomL. Fleming1NHLI, Imperial College London, London, United KingdomJ. Riley3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomL. Jeyasingham3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomA. Rowe7External Innovation, R&D IT, Janssen Research and Development, London, United KingdomK. Fichtner8Global Clinical Operations, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, United KingdomG. Roberts9Faculty of Medicine, University of Southampton, Southampton, United KingdomP. Bakke10Respiratory Medicine, Haukeland University Hospital, Bergen, NorwayF. Singer11Respiratory Medicine, Inselspital and University of Bern, Bern, SwitzerlandT. Geiser11Respiratory Medicine, Inselspital and University of Bern, Bern, SwitzerlandU. Frey11Respiratory Medicine, Inselspital and University of Bern, Bern, SwitzerlandI. Horvarth12Department of Pulmonology, Semmelweis University, Budapest, United KingdomR. Polosa13Medicine and Immunology Clinic, University of Catania, Catania, ItalyK. Bønnelykke14University Hospital, University Hospital, Copenhagen, Copenhagen, DenmarkN. Krug15Medicine, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, GermanyR. Middelveld16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenS.-E. Dahlen16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenB. Dahlen16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenG. Hedlin16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenS. Hashimoto2Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsB. Nordlund16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenJ. Musial17Medical College, Jagiellonian University, Krakow, PolandA. Woodcock6Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomC. Murray6Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomL. Pahus18Hopital Nord, Bureau De Recherche Clinique, Université De La Méditerranee, Marseille, FranceP. Chanez18Hopital Nord, Bureau De Recherche Clinique, Université De La Méditerranee, Marseille, FranceD. Myles3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomC. Compton19Horsham Research Center, Novartis Pharma AG, Horsham, United KingdomT.W. Higenbottam20Chiesi Research, Chiesi, London, United KingdomP. Montuschi21Istituto Di Farmacologia, Università Cattolica Del Sacro Cuore, Rome, ItalyJ. Vestbo22Lungemedicinsk Sektion, Hvidovre Hospital, Hvidovre, DenmarkL. Larsson4Clinical Research, AstraZeneca, Lund, SwedenT. Sandstrom23Respiratory and Allergy Division, University Hospital, Umeå, Umeå, SwedenH. Bisgaard14University Hospital, University Hospital, Copenhagen, Copenhagen, DenmarkS.S. Wagers24BioSci Consulting, BioSci Consulting, Maasmechelen, BelgiumP.H. Howarth9Faculty of Medicine, University of Southampton, Southampton, United KingdomE.H. Bel2Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsR. Djukanovic9Faculty of Medicine, University of Southampton, Southampton, United KingdomF. Chung1NHLI, Imperial College London, London, United KingdomP. Sterk2Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands
- Unbiased clustering of children with asthma or pre-school wheeze using the U-BIOPRED electronic nose platformBy P. Brinkman, S. Hashimoto, L.J. Fleming, G. Hedlin, H. Knobel, T.J. Vink, N. Rattray, M. Santonico, G. Pennazza, A. D'Amico, P. Montuschi, S. Fowler, J. Corfield, A. Rowe, P.F Singer, U. Frey, H. Bisgaard, A. Bush, S.S. Wagers, K.F. Chung, D.E. Shaw, I. Pandis, C. Compton, W. Siebold, A.T. Bansal, G. Roberts, W.M. van Aalderen, P.J. Sterk and U-BIOPRED study groupP. Brinkman1Dept. Respiratory Medicine, Academic Medical Center, Amsterdam, NetherlandsS. Hashimoto1Dept. Respiratory Medicine, Academic Medical Center, Amsterdam, NetherlandsL.J. Fleming2Imperial College, London, United KingdomG. Hedlin4Karolinska Institute, Stockholm, SwedenH. Knobel5Philips Research Laboratories, Eindhoven, NetherlandsT.J. Vink5Philips Research Laboratories, Eindhoven, NetherlandsN. Rattray6Manchester Institute of Biotechnology, Manchester, United KingdomM. Santonico7Center for Integrated Research–CIR, Unit of Electronics for Sensor Systems, Rome, ItalyG. Pennazza7Center for Integrated Research–CIR, Unit of Electronics for Sensor Systems, Rome, ItalyA. D'Amico8University of Rome Tor Vergata, Rome, ItalyP. Montuschi9Catholic University of the Sacred Heart, Rome, ItalyS. Fowler10University of Manchester and Lancashire Teaching Hospitals NHS Trust, Manchester, United KingdomJ. Corfield11AstraZeneca, Molndal, Sweden and Areteva, Nottingham, United KingdomA. Rowe12R&D IT, Janssen Research and Development, London, United KingdomP.F Singer13Inselspital and University of Bern, Bern, Switzerland14University Children's Hospital Zurich, Zurich, SwitzerlandU. Frey13Inselspital and University of Bern, Bern, SwitzerlandH. Bisgaard15Copenhagen University Hospital Gentofte, Copenhagen, DenmarkA. Bush2Imperial College, London, United KingdomS.S. Wagers16BioSci Consulting, Maasmechelen, BelgiumK.F. Chung2Imperial College, London, United KingdomD.E. Shaw17Nottingham City Hospital, Nottingham, United KingdomI. Pandis2Imperial College, London, United KingdomC. Compton18Novartis Pharma AG, Horsham, United KingdomW. Siebold19Boehringer Ingelheim Pharma GmbH&Co, Ingelheim am Rhein, GermanyA.T. Bansal20Acclarogen, Cambridge, United KingdomG. Roberts21University of Southampton, Southampton, United KingdomW.M. van Aalderen22Department of Paediatrics, Academic Medical Center, Amsterdam, NetherlandsP.J. Sterk1Dept. Respiratory Medicine, Academic Medical Center, Amsterdam, NetherlandsU-BIOPRED study group23U-BIOPRED Study Group Listed at http://www.europeanlung.org/en/assets/microsites/ubiopred/files/ubiopred_study_groups.pdf, Amsterdam, Netherlands
- Clinical and histological comparison of smoking and non-smoking patients with severe asthma in the U-BIOPRED cohortBy P.P.W. Hekking, S.J. Wilson, A.H. Wagener, A.R. Sousa, J. Corfield, D.E. Shaw, S.J. Fowler, L.J. Fleming, J.H. Riley, E. Jeyasingham, A. Rowe, W. Seibold, G. Roberts, P. Bakke, F. Singer, T. Geiser, U. Frey, I. Horvath, R. Polosa, N. Krug, J. Musial, L. Pahus, D. Myles, C. Compton, T.W. Higenbottam, P. Montuschi, U. Nihlén, T. Sandstrom, S.S. Wagers, P.H. Howarth, R. Djukanovic, K.F. Chung, I. Pandis, Y. Guo, A.T. Bansal, E.H. Bel and P.J. SterkP.P.W. Hekking1Respiratory Medicine, AMC, Amsterdam, NetherlandsS.J. Wilson2Faculty of Medicine, University of Southampton, Southampton, United KingdomA.H. Wagener1Respiratory Medicine, AMC, Amsterdam, NetherlandsA.R. Sousa3GSK, GSK, London, United KingdomJ. Corfield4AZ, AstraZeneca R&D Molndalm Sweden & Areteva Ltd, Nottingham, United KingdomD.E. Shaw5Respiratory Medicine, Nottingham city Hospital, Nottingham, United KingdomS.J. Fowler6Faculty of Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomL.J. Fleming7Faculty of Medicine, Imperial College, London, United KingdomJ.H. Riley3GSK, GSK, London, United KingdomE. Jeyasingham3GSK, GSK, London, United KingdomA. Rowe8R&D IT, Janssen Research and Development, London, United KingdomW. Seibold9Pharma GmbH&Co KG, Boehringer Ingelheim, Biberach an der Riss, GermanyG. Roberts2Faculty of Medicine, University of Southampton, Southampton, United KingdomP. Bakke10Respitatory Medicine, Haukeland University Hospital, Bergen, NorwayF. Singer11Faculty of Medicine, Inselspital and University of Bern, Bern, SwitzerlandT. Geiser11Faculty of Medicine, Inselspital and University of Bern, Bern, SwitzerlandU. Frey11Faculty of Medicine, Inselspital and University of Bern, Bern, SwitzerlandI. Horvath12Faculty of Medicine, Semnmelweis University, Budapest, HungaryR. Polosa13Faculty of Medicine, University of Catania, Catania, ItalyN. Krug14Fraunhofer, Institute for Toxocology and Exp. Medicine, Hannover, GermanyJ. Musial23Faculty of Medicine, Jagoellonian University, Krakow, PolandL. Pahus16Faculty of Medicine, Université de la Méditerranee, Marseille, FranceD. Myles3GSK, GSK, London, United KingdomC. Compton17Novartis, Pharma AG, Horsham, United KingdomT.W. Higenbottam18Chiesi, Chiesi, London, United KingdomP. Montuschi19Faculty of Medicine, Università Cattolica del Sacro Cuore, Rome, ItalyU. Nihlén4AZ, AstraZeneca R&D Molndalm Sweden & Areteva Ltd, Nottingham, United KingdomT. Sandstrom20University Hospital, Umea, Umea, SwedenS.S. Wagers21U-BIOPRED, BioSci Consulting, Maasmechelen, BelgiumP.H. Howarth2Faculty of Medicine, University of Southampton, Southampton, United KingdomR. Djukanovic2Faculty of Medicine, University of Southampton, Southampton, United KingdomK.F. Chung7Faculty of Medicine, Imperial College, London, United KingdomI. Pandis24Discovery Sciences Group, Imperial College, London, United KingdomY. Guo24Discovery Sciences Group, Imperial College, London, United KingdomA.T. Bansal22Acclarogen, Acclarogen, Cambridge, United KingdomE.H. Bel1Respiratory Medicine, AMC, Amsterdam, NetherlandsP.J. Sterk1Respiratory Medicine, AMC, Amsterdam, Netherlands
- eTRIKS IT platfroms for large-scale biomedical researchBy I. Pandis, Y. Guo, F. Guitton, X. Yang, K. Sun, S. Wang, N. Jullian, A.R. Sousa, A.T. Bansal, J. Corfield, S. Pavlidis, P.P. Hekking, L.J. Fleming, D. Shaw, G. Roberts, N. Fitch, J.H. Riley, S.S. Wagers, A. Rowe, I.M. Adcock, K.F. Chung, C. Auffray, P.J. Sterk and The U-BIOPRED Study GroupI. Pandis1Computing, Imperial College London, London, United KingdomY. Guo1Computing, Imperial College London, London, United KingdomF. Guitton1Computing, Imperial College London, London, United KingdomX. Yang1Computing, Imperial College London, London, United KingdomK. Sun1Computing, Imperial College London, London, United KingdomS. Wang1Computing, Imperial College London, London, United KingdomN. Jullian2European Institute for Systems Biology & Medicine, CNRS-ENS-UCBL, Université de Lyon, Lyon, FranceA.R. Sousa3Discovery Medicine, GlaxoSmithKline, Stevenage, United KingdomA.T. Bansal4Statistical Genetics, Acclarogen, Cambridge, United KingdomJ. Corfield5Pharmaceuticals, Areteva, Nottingham, United KingdomS. Pavlidis6Translational Informatics, Johnson & Johnson, London, United KingdomP.P. Hekking7Pulmonology, Academic Medical Center, Amsterdam, NetherlandsL.J. Fleming8National Heart & Lung Institute, Imperial College London, London, United KingdomD. Shaw9Paediatric Allergy and Respiratory Medicine, University of Southampton, Southampton, United KingdomG. Roberts10Paediatric Allergy and Respiratory Medicine, University of Southampton, Southampton, United KingdomN. Fitch11Consulting, BioSci Consulting, Brussels, BelgiumJ.H. Riley3Discovery Medicine, GlaxoSmithKline, Stevenage, United KingdomS.S. Wagers11Consulting, BioSci Consulting, Brussels, BelgiumA. Rowe6Translational Informatics, Johnson & Johnson, London, United KingdomI.M. Adcock8National Heart & Lung Institute, Imperial College London, London, United KingdomK.F. Chung8National Heart & Lung Institute, Imperial College London, London, United KingdomC. Auffray2European Institute for Systems Biology & Medicine, CNRS-ENS-UCBL, Université de Lyon, Lyon, FranceP.J. Sterk7Pulmonology, Academic Medical Center, Amsterdam, Netherlands1Computing, Imperial College London, London, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
